Tirzepatide offers a promising treatment for patients with obesity, chronic kidney disease, and heart failure, improving both ...

The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with ...

The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection fraction (HFpEF) compared with placebo at one year, ...

Edgewise Therapeutics, Inc., , a leading muscle disease biopharmaceutical company, today announced positive top-line data of EDG-7500 from the Phase 2 CIRRUS-HCM four-week trial in participants with ...

More than four years after a 77-year-old man walked into a Florida hospital with pain in his chest, a new report says preparing and eating feral pig meat was the likely cause of the man’s yearslong ...

Chronic inflammation is a serious health issue that requires careful management. Here is how following healthy lifestyle choices, along with medical interventions, can help reduce inflammation and ...

Those in favor of the classification argue that excess fat accumulation/distribution is linked to sustained and serious ...

Ahmad Masri, M.D., MS, Director of the Hypertrophic Cardiomyopathy Center at Oregon Health & Science University ... Saint Luke's Mid America Heart Institute. A new analysis from SEQUOIA-HCM of the ...